Bannoud N, Stupirski JC, Cagnoni AJ, Hockl PF, et al. Circulating galectin-1 delineates response to bevacizumab in melanoma patients and reprograms endothelial cell biology. Proc Natl Acad Sci U S A 2023;120:e2214350120.
PMID: 36634146